B. H. KEAN, M.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
For the past several decades, the field of clinical helminthology has had two major goals: finding a single drug that, when administered orally in one dose, would force the five major types of roundworms from the intestinal tract; and developing a drug that would kill circulating larvae or parasites localized in the tissues. There have been major limitations to achieving these goals. First, parasitologists have been slow to use some of the more precise methods of studying living organisms. They have too often been content to test new drugs in a rather haphazard fashion—with inadequate designs for therapeutic assessment and
KEAN BH. Thiabendazole—A New Anthelmintic Drug. Ann Intern Med. ;67:461–462. doi: 10.7326/0003-4819-67-2-461
Download citation file:
Published: Ann Intern Med. 1967;67(2):461-462.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use